Company: CI
Filing Date: 2025-09-02
Form Type: S-3ASR
Source: 0001140361-25-033568
Chunk: 11

Company: Cigna Group
Filing Date: 2025-09-02
Form: S-3ASR
Chunk 11
---
, including the period or periods, if any, within which, the price or prices at which, and the terms and conditions upon which the debt securities may be redeemed, in whole or in part, at our option or at your option; |

| • | the terms and conditions, if any, upon which we may have to repay the debt securities early at your option; |

| • | the place where we will pay principal, interest and any premium; |

| • | the currency or currencies, if other than the currency of the United States, in which principal, interest and any premium will be paid; |

| • | if other than denominations of $2,000 and any integral multiples of $1,000 thereof, the denominations in which the debt securities will be issued; |

| • | if the debt securities will not be issued in the form of global securities; |

| • | additional provisions, if any, relating to the discharge of our obligations under the debt securities; |

| • | whether the amount of payment of principal (or premium, if any) or interest, if any, will be determined with reference to one or more indices; |

| • | the portion of the principal amount of the debt securities to be paid upon acceleration of maturity thereof if other than 100%; |

| • | the terms and conditions upon which conversion or exchange of the debt securities may be effected, if any, including the initial conversion or exchange price or rate and any adjustments thereto and the period or periods when a conversion or exchange may be effected; |

| • | any authenticating or paying agents, registrars or other agents; |

| • | the application, if any, of defeasance and covenant defeasance provisions to the debt securities; |

| • | other specific terms, including any additional events of default, covenants or warranties; and |

| • | any other terms, which may supplement, modify or delete any provision of the indenture as it applies to that series, including any terms that may be required or advisable under applicable law or regulations or advisable in connection with the marketing of the debt securities. (Section 3.01) |

We may from time to time, without notice to or the consent of the holders of any series of debt securities, create and issue further debt securities of any such series ranking equally with, and having the same terms and conditions as, the debt securities of such series in all respects (